![]() |
市場調查報告書
商品編碼
1930107
全球血管封閉裝置市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量因素以及未來預測(2026-2034)Vessel Sealing Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
由於外科手術數量的增加以及對微創手術技術需求的成長,全球血管封閉裝置市場正經歷穩定成長。根據 Fortune Business Insights 預測,該市場規模預計在 2025 年達到 21.1 億美元,並在 2026 年達到 22.4 億美元。到 2034 年,市場規模預計將達到 37.7 億美元,在預測期(2026-2034 年)內以 6.69% 的複合年增長率成長。北美地區憑藉其先進的醫療基礎設施和較高的手術率,在 2025 年以 44.82% 的市場佔有率領先。
市場概覽
血管封閉器是一種先進的外科器械,用於在開放式手術和腹腔鏡手術中封閉動脈和靜脈。這些器械包括電熱雙極血管封閉器、超音波剪切器和混合能量系統。它們能夠有效率地閉合、切割和凝固血管,從而減少出血並改善手術效果。微創手術日益普及以及外科能量器械技術的進步是推動市場成長的關鍵因素。
市場驅動因素
全球外科手術數量的不斷增長是血管封閉器市場的主要驅動因素。根據美國國家生物技術資訊中心 (NCBI) 發布的數據,全球每年約進行 3.1 億例大型外科手術,光是美國每年就進行超過 4,500 萬例。此外,老年人口的增長(老年人易患慢性病和心血管疾病)也導致了住院和手術量的增加。
人們對先進外科技術的認識不斷提高、醫療保健支出不斷增長,以及已開發國家和新興國家訓練有素的外科醫生數量不斷增加,都進一步加速了血管封閉裝置的應用。
市場趨勢
影響市場的一個關鍵趨勢是向微創手術的轉變。這些手術具有許多優勢,例如減輕術後疼痛、縮短住院時間、加快復健速度、降低併發症風險。美國國家生物技術資訊中心 (NCBI) 2021 年的一項研究表明,與接受開放性手術的患者相比,接受微創手術的患者併發症更少。
全球每年約進行 1500 萬例腹腔鏡手術,其中約 80% 的手術使用了能量型器械,凸顯了對血管封閉技術日益增長的需求。
新冠疫情的影響
2020年,新冠疫情對市場成長造成了負面影響,主要原因是擇期手術的延遲以及醫療資源被重新分配用於新冠肺炎的治療。根據Healthium MedTech Ltd.的數據顯示,疫情期間全球手術量下降了約15%。供應鏈中斷和原材料短缺進一步影響了主要製造商的設備生產和收入。
然而,隨著2021年限制措施的逐步解除,手術得以恢復,推動了市場復甦,並帶動了血管封閉器械需求的反彈。
依市場區隔分析
依產品類型劃分,電熱血管封閉器佔市場主導地位,預計到2026年將保持66.68%的市場佔有率,這主要得益於頻繁的新產品發布以及在開放式和腹腔鏡手術中的廣泛應用。
依組件劃分,受手術數量不斷增加的推動,預計到2026年,器械類產品將佔市場主導地位,市場佔有率達78.77%。
依手術類型劃分,微創手術和腹腔鏡手術佔最大佔有率,而普通外科手術預計將以最高的複合年增長率增長。
依應用領域劃分,受心血管疾病盛行率上升的推動,預計到2026年,心胸外科手術將佔市場主導地位,市場佔有率達28.80%。
依最終用戶劃分,受住院患者和手術數量增加的推動,預計到2026年,醫院和門診手術中心(ASC)將佔市場87.80%的佔有率。
依地區分析
預計到2025年,北美市場規模將達到9.5億美元,主要得益於高額的醫療保健支出、有利的報銷政策以及技術創新。
歐洲憑藉著不斷增加的監管審批和產品上市,維持顯著的市場佔有率。
亞太地區正經歷快速成長,這主要得益於人口老化以及人們對先進外科技術的日益了解。
拉丁美洲以及中東和非洲地區預計將保持穩定成長,這得益於醫療基礎設施的改善和手術量的增加。
The global vessel sealing devices market is experiencing steady growth due to the increasing volume of surgical procedures and the growing preference for minimally invasive surgical techniques. According to Fortune Business Insights, the market was valued at USD 2.11 billion in 2025 and is projected to grow to USD 2.24 billion in 2026. By 2034, the market is expected to reach USD 3.77 billion, expanding at a CAGR of 6.69% during the forecast period (2026-2034). North America dominated the market with a 44.82% share in 2025, supported by advanced healthcare infrastructure and high surgical procedure rates.
Market Overview
Vessel sealing devices are advanced surgical instruments used to seal arteries and veins during open and laparoscopic surgeries. These devices include electro-thermal bipolar vessel sealers, ultrasonic shear devices, and hybrid energy systems. They enable efficient sealing, cutting, and coagulation of blood vessels, thereby reducing blood loss and improving surgical outcomes. The rising preference for minimally invasive procedures and technological advancements in surgical energy devices are key contributors to market growth.
Market Drivers
The increasing number of surgical procedures worldwide is a primary driver of the vessel sealing devices market. According to data published by the National Center for Biotechnology Information, approximately 310 million major surgeries are performed globally each year, with over 45 million surgeries conducted annually in the United States. Additionally, the growing geriatric population, which is more susceptible to chronic and cardiovascular diseases, is contributing to higher inpatient admissions and surgical volumes.
Rising awareness of advanced surgical techniques, increasing healthcare expenditure, and the growing number of trained surgeons in both developed and emerging economies are further accelerating the adoption of vessel sealing devices.
Market Trends
A significant trend shaping the market is the preferential shift toward minimally invasive surgical procedures. These procedures offer benefits such as reduced postoperative pain, shorter hospital stays, faster recovery, and lower complication risks. According to a 2021 NCBI study, patients undergoing minimally invasive surgeries experienced fewer complications compared to those undergoing open surgeries.
Approximately 15 million laparoscopic procedures are performed globally each year, and energy-based devices are used in nearly 80% of laparoscopic surgeries, highlighting the growing demand for vessel sealing technologies.
Impact of COVID-19
The COVID-19 pandemic had a negative impact on market growth in 2020, primarily due to the postponement of elective surgeries and the reallocation of healthcare resources toward COVID-19 treatment. According to Healthium MedTech Ltd., global surgical procedures declined by nearly 15% during the pandemic. Supply-chain disruptions and raw-material shortages further affected device production and revenue generation for key manufacturers.
However, the gradual lifting of restrictions in 2021 led to the resumption of surgeries, supporting market recovery and renewed demand for vessel sealing devices.
Market Segmentation Insights
By product, electro-thermal vessel sealer devices dominated the market and are projected to hold a 66.68% share in 2026, driven by frequent product launches and broad adoption in both open and laparoscopic surgeries.
By components, the instruments segment is expected to dominate with a 78.77% share in 2026, owing to rising surgical volumes.
By surgery type, laparoscopic surgery held the largest share due to its minimally invasive nature, while general surgery is expected to grow at the fastest CAGR.
By application, the cardiothoracic segment is projected to dominate with a 28.80% share in 2026, driven by the rising prevalence of cardiovascular diseases.
By end user, hospitals and ambulatory surgical centers (ASCs) are expected to account for 87.80% of the market in 2026, supported by high inpatient admissions and surgical procedure rates.
Regional Analysis
North America generated USD 0.95 billion in 2025, driven by high healthcare spending, favorable reimbursement policies, and technological innovation.
Europe held a considerable market share due to increasing regulatory approvals and product launches.
Asia Pacific is witnessing rapid growth due to a rising aging population and increasing awareness of advanced surgical technologies.
Latin America and the Middle East & Africa are expected to grow steadily, supported by improving healthcare infrastructure and increasing surgical volumes.
Competitive Landscape
The market is consolidated, with leading players such as Medtronic, Johnson & Johnson Services, Olympus Corporation, and B. Braun SE holding a strong presence. These companies focus on R&D investments, product innovation, regulatory approvals, and strategic acquisitions to strengthen their market positions.
Conclusion
The global vessel sealing devices market is set to grow from USD 2.11 billion in 2025 to USD 3.77 billion by 2034, driven by rising surgical volumes, increasing adoption of minimally invasive procedures, and continuous technological advancements. Although high device costs and limited awareness in emerging regions remain challenges, strong R&D pipelines, expanding healthcare infrastructure, and growing surgeon preference for advanced energy devices are expected to support sustained market growth during the forecast period.
Segmentation By Product
By Components
By Surgery Type
By Application
By End-user
By Region